Current Insights into Immunotherapy Approaches for Food Allergy.

Abstract

In the last decade, there has been increasing research dedicated to food immunotherapy to induce clinical desensitization and provide protection by increasing clinical reaction thresholds. Results from recent food immunotherapy studies with differing routes of administration (oral, sublingual, and epicutaneous) suggest that food immunotherapy can induce clinical desensitization with varying levels of safety, however lasting tolerance has not been demonstrated. Furthermore, treatment side effects and dosing logistics may make the therapies difficult for some supporting the need for alternative treatment approaches. Peptide immunotherapy and DNA vaccine approaches should in theory allow for safer administration by decreasing allergenicity but proof of their clinical efficacy and immunogenicity remains to be proven. Biologic agents may allow for increased safety and rapid up-dosing of immunotherapy with the added benefit of treating multiple allergens simultaneously.

• Authors: Jessica D Macdougall, A Wesley Burks, Edwin H Kim
• Journal: ImmunoTargets and therapy (Immunotargets Ther) Vol. 10 Pg. 1-8 ( 2021) ISSN: 2253-1556 [Print] New Zealand
• PMID: 33537245 (Publication Type: Journal Article, Review)
• Copyright: © 2021 Macdougall et al.